Orbimed Capital GP IV LLC
SEC-identified person · CIK 1502240 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tela Bio, Inc. TELA | Officer | filed 2019 - 2024 |
| Acutus Medical, Inc. AFIB | Director | filed 2020 - 2021 |
| Alector, Inc. ALEC | Director | filed 2019 - 2020 |
| Principia Biopharma Inc. PRNB | Officer | filed 2018 - 2019 |
| Armo Biosciences, Inc. ARMO | Director | filed 2018 - 2018 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016 - 2018 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017 - 2017 |
| Relypsa Inc RLYP | Officer | filed 2013 - 2016 |
| Otonomy, Inc. OTIC | Director | filed 2014 - 2015 |
| Intercept Pharmaceuticals, INC. ICPT | Director | filed 2012 - 2015 |
| Mirati Therapeutics, Inc. mrtx | Officer | filed 2013 - 2015 |
| Anthera Pharmaceuticals Inc ANTH | Director | filed 2010 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.